Immediate Impact
1 by Nobel laureates 56 standout
Citing Papers
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
2022 Standout
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
Works of Gary W. Ross being referenced
Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy
1994
Lack of histopathological correlation of malignant ependymomas with postoperative survival
1989
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gary W. Ross | 140 | 149 | 206 | 142 | 11 | 472 | |
| CHARLES D. KENNARD | 61 | 106 | 151 | 113 | 12 | 475 | |
| H.‐H. Hugo | 109 | 212 | 99 | 113 | 18 | 442 | |
| K. Weigel | 116 | 192 | 167 | 84 | 22 | 540 | |
| Corinne Bouvier‐Labit | 57 | 190 | 327 | 104 | 16 | 564 | |
| Salvador Somaza | 124 | 156 | 296 | 246 | 15 | 566 | |
| Shio Shimada | 103 | 158 | 74 | 173 | 14 | 417 | |
| Katie L. Pricola | 78 | 150 | 186 | 109 | 12 | 513 | |
| Asis Kumar Karak | 72 | 109 | 233 | 99 | 30 | 449 | |
| Linda E. Ansbacher | 67 | 344 | 99 | 132 | 19 | 550 | |
| Saeed T. Vakili | 105 | 257 | 61 | 146 | 21 | 540 |
All Works
Loading papers...